Requires the Comptroller General to assess wearable medical devices' use in clinical decision-making, focusing on their treatment-prescribing accuracy, AI's role in enhancing capabilities, and policy options to optimize benefits and address development challenges.
Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the risk subdomain are described.
All other risk subdomains had no coverage in this document.
Risk Coverage Summary
The document has minimal coverage of risk domains, with brief mentions of AI system safety (7.3 - lack of robustness) and human-computer interaction (5.1 - overreliance). The focus is on assessing capabilities and limitations rather than governing specific risks. Coverage is limited to 2-3 subdomains at minimal levels.
Good coverage — Comprehensive governance measures or mitigations with clear procedures relating to the sector are explicitly described.
Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the sector are described.
All other sectors had no coverage in this document.
Sectors Summary
The document primarily governs the Health Care and Social Assistance sector through its focus on wearable medical devices used in clinical decision-making. It also has minimal coverage of Scientific Research and Development Services through the mandated technology assessment.
Hard Law
Legislative Status Summary
This is a binding legislative provision enacted by the United States Congress that mandates the Comptroller General to conduct a technology assessment and submit a report to Congress within a specified timeframe.
Proposer
Target
Enforcer
Monitor
Lifecycle stages covered by the documents, as defined in the OECD Framework for the Classification of AI Systems
AI Lifecycle Summary
The document addresses multiple lifecycle stages with primary focus on deployment and operational monitoring of wearable medical devices. It covers the use of AI models in clinical settings, validation of treatment accuracy, and ongoing assessment of capabilities and limitations.
Terms relating to technical scope that are mentioned or implicitly referenced in the document
Technical Scope Summary
The document explicitly mentions artificial intelligence in the context of augmenting wearable medical device capabilities. It focuses on AI systems used in clinical decision-making but does not specify particular AI model types, compute thresholds, or distinguish between frontier, general purpose, or task-specific AI.
Document data from AGORA, CSET Emerging Technology Observatory.